Inventor
Xiaojiang Cui
Inventor
Arcadia, CA, US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C12NMicroorganisms or enzymes27%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms18%
A61KPreparations for medical, dental or toiletry purposes9%
C07KPeptides9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
10,738,323Generation of induced pluripotent stem cells from normal human mammary epithelial cells202010,253,368Molecular signatures of ovarian cancer20199,850,293Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle20179,074,253'Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015Patents assigned to WAYNE JOHN CANCER INST (1)· patent assignee history
2015Based in Pearland, TX, US· patent location history
2017–2020Patents assigned to CEDARS SINAI MEDICAL CENTER (3)· patent assignee history
2017Based in Los Angeles, CA, US· patent location history
2019–2020Based in Arcadia, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CEDARS SINAI MEDICAL CENTER | 3 | 2017–2020 |
| WAYNE JOHN CANCER INST | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Arcadia, California, US | 2 | 2019–2020 |
| Los Angeles, California, US | 1 | 2017 |
| Pearland, Texas, US | 1 | 2015 |